Sirukumab, a human anti-interleukin-6 monoclonal antibody

(20:54)

Sirukumab is safe and efficacious in the management of rheumatoid arthritis

(4:26)

5 Questions on Sirukumab FDA Hearing - Dr. Cush

(9:25)

5 Questions on Sirukumab FDA Hearing - Dr. Gibofsky

(10:14)

The RheumNow Week in Review – 4 August 2017

(11:37)

FDA declines to approve J\u0026J arthritis drug sirukumab

(2:29)

Arthrite rhumatoïde: infos et conseils

(8:53)

Nefritis Lúpica | KDIGO 2024 #AlDíaConLasGuías

(37:58)

Transmisión en directo de reumatologiamx

(1:15:)

Discovery of IL-6 by Prof. Kishimoto

(56:51)

Does Your Immune System Listen To Your Thoughts?

(6:35)

Immune system basics and the immune dysregulation of PI disorders: 2024 PI Conference

(38:46)

IL6 in Health and Disease

(36:55)

Novel Treatments for Rheumatoid Arthritis

(3:28)

IL-23 Inhibitors and Other Emerging Psoriasis Treatments

(24:2)

IL-6 Targeting

(29:58)

Leonard Calabrese, DO | Immune System

(23:58)

Why Personal Behavior Affects Immune Mediated Inflammatory Diseases

(1:16)

Rheumatoid Arthritis Video - Brigham and Women's Hospital

(7:28)

TYK2 Inhibitors Show Efficacy in Psoriatic Arthritis - Medpage Today

(6:18)

Researcher comment: Tildrakizumab shows promise for PsA

(8:46)

Dr. Len Calabrese on Herpes Zoster

(1:8)

Dr. Calabrese

(1:50:6)

Effect of Interleukin-6 Receptor Blockade on Surrogates of Vascular Risk in RA

(29:7)

Expert Recommendations from ACR on Biologics Efficacy and Safety

(30:46)

Efficacy of IL-6 Blockade in Rheumatoid Arthritis

(4:45)

Addressing Unmet Needs in RA: A Physician-Patient Discussion

(28:29)